1-84408444-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_021233.3(DNASE2B):āc.311A>Cā(p.Asn104Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000932 in 1,608,928 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_021233.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNASE2B | NM_021233.3 | c.311A>C | p.Asn104Thr | missense_variant | 3/6 | ENST00000370665.4 | NP_067056.2 | |
DNASE2B | XM_047426625.1 | c.74A>C | p.Asn25Thr | missense_variant | 2/5 | XP_047282581.1 | ||
DNASE2B | NM_058248.2 | c.-314A>C | 5_prime_UTR_variant | 1/4 | NP_490649.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNASE2B | ENST00000370665.4 | c.311A>C | p.Asn104Thr | missense_variant | 3/6 | 1 | NM_021233.3 | ENSP00000359699 | P1 | |
DNASE2B | ENST00000370662.3 | c.-314A>C | 5_prime_UTR_variant | 1/4 | 1 | ENSP00000359696 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152148Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000490 AC: 12AN: 244906Hom.: 0 AF XY: 0.0000376 AC XY: 5AN XY: 132922
GnomAD4 exome AF: 0.00000892 AC: 13AN: 1456780Hom.: 0 Cov.: 30 AF XY: 0.00000828 AC XY: 6AN XY: 724612
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152148Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74326
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2021 | The c.311A>C (p.N104T) alteration is located in exon 3 (coding exon 3) of the DNASE2B gene. This alteration results from a A to C substitution at nucleotide position 311, causing the asparagine (N) at amino acid position 104 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at